Novel hybrid block copolymer nanocarrier systems to load lipophilic drugs prepared by microphase inversion method

被引:0
作者
Andrea Granada
Issei Otsuka
Thiago Caon
Marcos Antonio Segatto Silva
Valdir Soldi
Redouane Borsali
机构
[1] Université Grenoble Alpes,Programa de Pós
[2] CNRS,Graduação em Farmácia (PGFAR), Departamento de Ciências Farmacêuticas
[3] CERMAV,Programa de Pós
[4] Universidade Federal de Santa Catarina,Graduação em Química, Departamento de Química
[5] Universidade Federal de Santa Catarina,undefined
来源
Journal of Polymer Research | 2017年 / 24卷
关键词
Nanoparticle; Block copolymer; Oligosaccharide; Polycaprolactone; Self-assembly; Drug delivery system;
D O I
暂无
中图分类号
学科分类号
摘要
Nanoparticles based on block copolymers of oligosaccharides [β-cyclodextrin (βCyD) and maltoheptaose (Mal7)] and poly(ε-caprolactone) (PCL) were prepared by microphase inversion method. Zeta-potential, particle size measurements and morphological analysis of drug-free and drug-loaded nanoparticles were performed by using, respectively, laser-doppler anemometry, dynamic and static light scattering and transmission electron microscopy. ρ-Ratio values were correlated with transmission electron microscopy observations. Both types of amphiphilic block copolymers, βCyD-b-PCL5k and Mal7-b-PCL5k, self-assembled in water to form spherical vesicles, presented a hydrodynamic diameter of 72 and 34 nm, respectively. The incorporation of drugs into nanoparticles did not affect significantly the particle size for βCyD-b-PCL5k-based nanoparticles with progesterone, unlike the other tested systems. On the other hand, all nanoparticles (with and without drug) were negatively charged. Both nanoparticulate systems showed high drug loading efficiency (higher than 95%), confirming their suitability as delivery system for lipophilic drugs.
引用
收藏
相关论文
共 162 条
  • [1] Aachmann FL(2003)Structural background of cyclodextrin-protein interactions Protein Eng 16 905-912
  • [2] Otzen DE(2012)Chitosan/cyclodextrin nanoparticles as drug delivery system J Incl Phenom Macrocycl Chem 72 127-136
  • [3] Larsen KL(2002)Study on the inclusion complexes of bromazepam with beta- and beta-hydroxypropyl-cyclodextrins J Pharm Biomed Anal 28 761-769
  • [4] Wimmer R(2001)Structure formation by polysaccharides in concentrated solution Biomacromolecules 2 342-353
  • [5] Ammar HO(2014)Chitosan-decorated polystyrene-b-poly(acrylic acid) polymersomes as novel carriers for topical delivery of finasteride Eur J Pharm Sci 52 165-172
  • [6] El-Nahhas SA(2001)Inclusion complex of piroxicam with beta-cyclodextrin and incorporation in cationic microemulsion. In vitro drug release and in vivo topical anti-inflammatory effect Int J Pharm 222 45-55
  • [7] Ghorab MM(2014)Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies Int J Nanomedicine 9 1231-1242
  • [8] Salama AH(2008)Development and validation of an HPLC method to quantify camptothecin in polymeric nanocapsule suspensions J AOAC Int 91 551-556
  • [9] Archontaki HA(2013)Nifedipine-loaded polymeric nanocapsules: validation of a stability-indicating HPLC method to evaluate the drug entrapment efficiency and in vitro release profiles J AOAC Int 96 276-281
  • [10] Vertzoni MV(2009)Synthesis, chromatographic evaluation and hydrophilic interaction/reversed-phase mixed-mode behavior of a "Click beta-cyclodextrin" stationary phase J Chromatogr A 1216 257-263